Advanced liver cancer: Selective internal radiotherapy safer than sorafenib

While advanced or inoperable hepato-cellular carcinoma patients treated with selective internal radiotherapy showed similar overall survival to patients receiving sorafenib, it caused significantly fewer treatment-related adverse effects and delivered significantly better quality of life.
Medical News Today